Literature DB >> 19540430

Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice.

Ren-Wen Han1, Min Chang, Ya-Li Peng, Lian-yong Qiao, Xin-Qiang Yin, Wei Li, Rui Wang.   

Abstract

Neuropeptide S (NPS), the endogenous ligand of NPS receptor (NPSR), regulates many biological functions, including arousal, anxiety, locomotion and food intake. NPSR mRNA is expressed in several regions of central autonomic network through which the brain controls visceromotor and other responses essential for survival. However, the role of NPS/NPSR system in regulating gastrointestinal motor is still unknown. Here, we studied the effects of NPS on distal colonic transit in mice. Intracerebroventricular (i.c.v.) injection of NPS (1-1000 pmol) inhibited fecal pellet output and bead expulsion in a dose-dependent manner. However, intraperitoneal injection of NPS (1000 and 10000 pmol) did not affect fecal pellet output and bead expulsion. In vitro, NPS (0.1-10 microM) also did not modulate distal colonic contractions. Furthermore, i.c.v. co-administration of [D-Val(5)]NPS, a pure and potent NPSR antagonist, dose-dependently antagonized the inhibitory effects of NPS on fecal pellet output and bead expulsion. In conclusion, our results firstly indicate that central NPS inhibits distal colonic transit through the activation of central NPSR, which implicate that NPS/NPSR system might be a new target to treat function disorder of distal colon.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540430     DOI: 10.1016/j.peptides.2009.03.012

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  Association of TNFSF15 polymorphism with irritable bowel syndrome.

Authors:  Marco Zucchelli; Michael Camilleri; Anna Nixon Andreasson; Francesca Bresso; Aldona Dlugosz; Jonas Halfvarson; Leif Törkvist; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Richard H Duerr; Magnus Simren; Greger Lindberg; Lars Agreus; Paula Carlson; Alan R Zinsmeister; Mauro D'Amato
Journal:  Gut       Date:  2011-06-02       Impact factor: 23.059

2.  Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice.

Authors:  A Stengel; M Goebel-Stengel; L Wang; M Larauche; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-06       Impact factor: 3.598

Review 3.  Novel transmitters in brain stem vagal neurocircuitry: new players on the pitch.

Authors:  Mehmet Bülbül; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

4.  Neuropeptide s receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders (gastroenterology 2010;138:98-107).

Authors:  Jung Mook Kang
Journal:  J Neurogastroenterol Motil       Date:  2010-04-28       Impact factor: 4.924

5.  Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders.

Authors:  Michael Camilleri; Paula Carlson; Alan R Zinsmeister; Sanna McKinzie; Irene Busciglio; Duane Burton; Marco Zucchelli; Mauro D'Amato
Journal:  Gastroenterology       Date:  2009-09-02       Impact factor: 22.682

6.  Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome.

Authors:  Guanqun Chao; Zhaojun Wang; Shuo Zhang
Journal:  J Inflamm Res       Date:  2021-04-14

7.  Neuropeptide S reduces duodenal bicarbonate secretion and ethanol-induced increases in duodenal motility in rats.

Authors:  Wan Salman Wan Saudi; Markus Sjöblom
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 8.  The Neural Network of Neuropeptide S (NPS): Implications in Food Intake and Gastrointestinal Functions.

Authors:  Luca Botticelli; Emanuela Micioni Di Bonaventura; Massimo Ubaldi; Roberto Ciccocioppo; Carlo Cifani; Maria Vittoria Micioni Di Bonaventura
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.